11Feb 2023
Impact of long‐acting implantable LYR‐210 corticosteroid matrices on quality of life of patients with chronic rhinosinusitis in the LANTERN study

Impact of long‐acting implantable LYR‐210 corticosteroid matrices on quality of life of patients with chronic rhinosinusitis in the LANTERN study

Chronic rhinosinusitis (CRS) carries a significant disease burden that negatively impacts the QoL of patients. Therefore, long-acting, local anti‐inflammatory treatments that improve the QoL of CRS patients are needed. This study found that LYR‐210 (7500μg) significantly improved scores for SNOT‐22 subdomains and SF‐36v2 at week 24.

  • #ent

Like

Save

Share